Ergoteles LLC Jazz Pharmaceuticals PLC Transaction History

Ergoteles LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$129.72 - $159.85 $2.23 Million - $2.75 Million	-17,196 Reduced 92.68%	1,359 $216,000
Q3 2022 Nov 14, 2022	BUY	$126.59 - $161.18 $2.35 Million - $2.99 Million	18,555 New	18,555 $2.47 Million
Q2 2022 Aug 12, 2022	SELL	$141.59 - $168.66 $205,588 - $244,894	-1,452 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$129.64 - $160.7 $198,089 - $245,549	-1,528 Reduced 51.28%	1,452 $226,000
Q4 2021 Feb 14, 2022	BUY	$119.87 - $145.67 $357,212 - $434,096	2,980 New	2,980 $380,000
Q1 2021 May 12, 2021	SELL	$150.19 - $173.5 $330,418 - $381,700	-2,200 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$140.71 - $165.05 $309,562 - $363,110	2,200 New	2,200 $363,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.